Ticker brief

PACB

last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
21
authors 14d
16
crowd 14d
-0.0σ

No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.

Sentiment — last 14 days
daily mean sentiment, 2026-10-02 → 2026-10-09 · now +0.10 (−1 bearish … +1 bullish)
Who spoke16
authorgradetrader scoresignalsmean sent
@KakashiCapital_B-0.193+0.55
@OptimalinvestmeC-2.282+0.40
@TheNewMoney_appC·2+0.48
@Analytica_XB-0.292-0.07
@TickeronC+1.531+0.20
@kiantradesC-1.011+0.45
@LogicalThesisA-1.211-0.50
@OptionsFlowBossC·1+0.50
@zohmbasticC-2.941+0.35
@OptionsC·1+0.35
@StevendiazB-0.491-0.45
@UTEX_ioC+0.041+0.35
@fwpharmaB-1.911+0.20
@MMatters22596C-0.731+0.40
@cnfinancewatchB-1.231+0.45
@AtlasShrug1A-1.101+0.55
Recent signals21of 21 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-10-09@AtlasShrug1+0.55Author discloses DNA and PACB entries, a core biotech holding, and continued avoidance of NUAI.·
2026-10-09@Analytica_X-0.35Reports declines of 15%-28% and brief stated drivers for four stocks.·
2026-10-08@cnfinancewatch+0.45Presents a long-term biotech growth basket spanning genomics, AI drug discovery and related platforms.·
2026-10-07@Optimalinvestme+0.35Author publishes a watchlist of allegedly strongest cheap stocks and acquisition candidates.·
2026-10-07@MMatters22596+0.40Presents a long-term biotech basket organized by genomics and AI drug-discovery layers.·
2026-10-07@Analytica_X+0.20Quantifies abnormal trading volume and divergent price action in SDEV and PACB.·
2026-10-06@TheNewMoney_app+0.60Reports PACB $3 calls already up 226.7%.·
2026-10-06@fwpharma+0.20TychoBio selects PacBio technology for rare-disease AI model training.·
2026-10-06@UTEX_io+0.35Reports a sequencing partnership for AI-driven rare-disease drug discovery.·
2026-10-06@Stevendiaz-0.45Finds these biotech names difficult to invest in due to cash burn and minimal revenue.·
2026-10-05@Options+0.35Reports unusual call activity in PACB and UMC while promoting a podcast discussion.·
2026-10-05@zohmbastic+0.35Reports PACB finishing near its end-of-day high.·
2026-10-05@OptionsFlowBoss+0.50Lists unusually bullish options-volume multiples near the close.·
2026-10-05@TheNewMoney_app+0.35Reports a large purchase of PACB 4 calls expiring in 2029.·
2026-10-05@LogicalThesis-0.50Expresses a desire, but not intent, to short a genomics basket.·
2026-10-05@kiantrades+0.45Enthusiastic reaction to PACB weekly performance.·
2026-10-05@Tickeron+0.20Lists small-cap weekly winners and losers; first six winners retained under the ticker cap.·
2026-10-05@KakashiCapital_+0.55Remains constructive on NAUT and PACB and enthusiastically endorses their market area.·
2026-10-04@KakashiCapital_+0.60Discloses going relatively heavy into proteomics and expanding PACB and NAUT holdings Friday.·
2026-10-03@Optimalinvestme+0.45Lists the strongest weekly-closing stocks while warning that ANPA often fades after off-hours moves.·
2026-10-02@KakashiCapital_+0.50Notes continued NAUT strength and expects PACB to lift related stocks next week.·

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.